Amit Akirov, MD

Researchers analyzed the autopsies of patients who died from COVID-19 to understand the pathophysiology of COVID-19-related myopathy.

Researchers assessed whether zolpidem (priming) is required for partial reinforcement or whether intermittent dosing with placebos can be effective for acute and extended treatment for patients with chronic insomnia.

Authors of a commentary assessed the role of IL-1 receptor antagonism, specifically anakinra, in the treatment of patients with severe COVID-19.